Related references
Note: Only part of the references are listed.Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study
Shih-Wei Lai et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Use of Antidiabetic Agents and the Risk of Pancreatic Cancer: A Case-Control Analysis
Michael Bodmer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Metformin and breast cancer risk: a meta-analysis and critical literature review
Nananda F. Col et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Use of Metformin Is Not Associated with a Decreased Risk of Colorectal Cancer: A Case-Control Analysis
Michael Bodmer et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives Results from a large population-based follow-up study
Rikje Ruiter et al.
DIABETES CARE (2012)
Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients
S. Bo et al.
DIABETES OBESITY & METABOLISM (2012)
Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data
T. P. van Staa et al.
DIABETOLOGIA (2012)
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials
R. J. Stevens et al.
DIABETOLOGIA (2012)
Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Zhi-Jiang Zhang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Diabetes, Metformin, and Breast Cancer in Postmenopausal Women
Rowan T. Chlebowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Metformin and cancer: new applications for an old drug
Taxiarchis V. Kourelis et al.
MEDICAL ONCOLOGY (2012)
Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
Davide Soranna et al.
ONCOLOGIST (2012)
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
Hiroshi Noto et al.
PLOS ONE (2012)
Prognostic Influence of Metformin as First-Line Chemotherapy for Advanced Nonsmall Cell Lung Cancer in Patients With Type 2 Diabetes
Ben-Xu Tan et al.
CANCER (2011)
Metformin and Incident Breast Cancer among Diabetic Women: A Population-Based Case-Control Study in Denmark
Jaclyn Lee Fong Bosco et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Metformin and the Incidence of Prostate Cancer in Patients with Type 2 Diabetes
Laurent Azoulay et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Low HDL Cholesterol, Metformin Use, and Cancer Risk in Type 2 Diabetes The Hong Kong Diabetes Registry
Xilin Yang et al.
DIABETES CARE (2011)
Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
Matteo Monami et al.
DIABETES CARE (2011)
Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes
Assiamira Ferrara et al.
DIABETES CARE (2011)
Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer A retrospective cohort study of older Medicare patients
Nancy E. Morden et al.
DIABETES CARE (2011)
Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes A meta-analysis
Zhi-Jiang Zhang et al.
DIABETES CARE (2011)
Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study
L. G. Mellbin et al.
DIABETOLOGIA (2011)
Use of metformin and the risk of ovarian cancer: A case-control analysis
Michael Bodmer et al.
GYNECOLOGIC ONCOLOGY (2011)
Impact of Metformin on the Prognosis of Cirrhosis Induced by Viral Hepatitis C in Diabetic Patients
Gisele Nkontchou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Angiotensin Receptor Blockade and Risk of Cancer in Type 2 Diabetes Mellitus: A Nationwide Case-Control Study
Chia-Hsuin Chang et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli health maintenance organization: a historical cohort study
Andreas E. Buchs et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort
Dorothee M. Baur et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort
Hans-Werner Hense et al.
DIABETOLOGY & METABOLIC SYNDROME (2011)
Epidemiological aspects of neoplasms in diabetes
Antonio Nicolucci
ACTA DIABETOLOGICA (2010)
Association of Diabetes Duration and Diabetes Treatment With the Risk of Hepatocellular Carcinoma
Manal M. Hassan et al.
CANCER (2010)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes - ZODIAC-16
Gijs W. D. Landman et al.
DIABETES CARE (2010)
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Michael Bodmer et al.
DIABETES CARE (2010)
Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes
D. Williams-Herman et al.
DIABETES OBESITY & METABOLISM (2010)
Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes
P. Aschner et al.
DIABETES OBESITY & METABOLISM (2010)
Use of sulphonylurea and cancer in type 2 diabetes-The Hong Kong Diabetes Registry
Xilin Yang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials
P. D. Home et al.
DIABETOLOGIA (2010)
Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure
S. L. Bowker et al.
DIABETOLOGIA (2010)
Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection
Takumi Kawaguchi et al.
LIVER INTERNATIONAL (2010)
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
Valter Donadon et al.
LIVER INTERNATIONAL (2010)
Sulphonylureas and cancer: a case-control study
Matteo Monami et al.
ACTA DIABETOLOGICA (2009)
Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study
Jonathan L. Wright et al.
CANCER CAUSES & CONTROL (2009)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
Antonino Belfiore et al.
ENDOCRINE REVIEWS (2009)
Metformin: diamonds are forever
N. Papanas et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Donghui Li et al.
GASTROENTEROLOGY (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Marc J. Gunter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial
Soren S. Lund et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Antidiabetic Medication and Prostate Cancer Risk: A population-based Case-Control Study
Teemu J. Murtola et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Insulin therapy and colorectal adenoma risk among patients with type 2 diabetes mellitus: A case-control study in Korea
Yong Woo Chung et al.
DISEASES OF THE COLON & RECTUM (2008)
Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients - A retrospective cohort study
M. Monami et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2008)
Thiazolidinedione Therapy Is Not Associated With Increased Colonic Neoplasia Risk in Patients With Diabetes Mellitus
James D. Lewis et al.
GASTROENTEROLOGY (2008)
Efficacy and Safety of Vildagliptin Monotherapy during 2-Year Treatment of Drug-naive Patients with Type 2 Diabetes: Comparison with Metformin
B. Goeke et al.
HORMONE AND METABOLIC RESEARCH (2008)
Metformin for the treatment of the polycystic ovary syndrome
John E. Nestler
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cancer incidence among patients treated with antidiabetic pharmacotherapy
Susan A. Oliveria et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2008)
Quality of diabetes care among cancer survivors with diabetes
Nancy L. Keating et al.
MEDICAL CARE (2007)
Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System
Maria E. Ramos-Nino et al.
BMC MEDICINE (2007)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
Evaluation of the quality of prognosis studies in systematic reviews
JA Hayden et al.
ANNALS OF INTERNAL MEDICINE (2006)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Comparative outcomes study of metformin intervention versus conventional approach - The COSMIC approach study
DR Cryer et al.
DIABETES CARE (2005)
Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus:: A double-blind, randomized trial
G Schernthaner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Insulin-like growth factors and neoplasia
MN Pollak et al.
NATURE REVIEWS CANCER (2004)
One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes
M Hanefeld et al.
DIABETES CARE (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Advanced methods in meta-analysis: multivariate approach and meta-regression
HC van Houwelingen et al.
STATISTICS IN MEDICINE (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
A comparison of methods to detect publication bias in meta-analysis
P Macaskill et al.
STATISTICS IN MEDICINE (2001)
Share Paper
